COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)		1 Months Ended		12 Months Ended
	Oct. 15, 2015	Aug. 31, 2020	Apr. 30, 2013	Sep. 30, 2020	Sep. 30, 2019
Non current assets				$ 1,700,000
Cash paid related to finance leases				1,900,000
Additional expense				$ 5,900,000
Weighted average discount rate				88.00%
Maturity years				8 years 1 month 6 days
Interest				$ 1,200,000
Research and development expenses				80,000
Rental income				39,000	$ 73,000
Book value of operating lease - liability				$ 1,200,000
Operating lease liability, description				the balance of the operating lease liability is approximately $1.3 million, of which approximately $0.1 million is current.
Operating lease expense				$ 268,000
Cash paid related to operating leases				238,000
Right of use asset				16,500,000
Clinical service				12,000,000
Finance lease liability				13,500,000
Finance Leases[Member]
Finance lease liability				$ 12.7
Finance lease liability, description				the balance of the finance lease liability is approximately $12.7 million, of which approximately $0.9 million is current.
Ergomed [Member]
Research and development expenses				$ 33,400,000
Net of discount				11,100,000
Lease Agreement[Member]
Estimated cost		$ 10,500,000
Cost incurred		$ 3,100,000
Co-Development And Revenue Sharing Agreement [Member]
Research and development expenses				2,000,000.0	2,800,000
Clinical service	$ 2,000,000		$ 10,000,000
Net of discount				$ 600,000	$ 1,000,000.0